These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 31407378

  • 1. Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.
    Ramesh K, Matta SA, Chew FT, Mok YK.
    Allergy; 2020 Feb; 75(2):403-411. PubMed ID: 31407378
    [Abstract] [Full Text] [Related]

  • 2. Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.
    Miyai M, Matsumoto Y, Yamanishi H, Yamamoto-Tanaka M, Tsuboi R, Hibino T.
    J Invest Dermatol; 2014 Jun; 134(6):1665-1674. PubMed ID: 24390132
    [Abstract] [Full Text] [Related]

  • 3. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P, Furio L, Teson M, Berretti M, El Hachem M, Zambruno G, Hovnanian A, D'Alessio M.
    Hum Mol Genet; 2012 Oct 01; 21(19):4187-200. PubMed ID: 22730493
    [Abstract] [Full Text] [Related]

  • 4. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugimoto S, Morizane S, Nomura H, Kobashi M, Sugihara S, Iwatsuki K.
    J Dermatol Sci; 2018 Nov 01; 92(2):181-187. PubMed ID: 30270115
    [Abstract] [Full Text] [Related]

  • 5. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugihara S, Sugimoto S, Tachibana K, Kobashi M, Nomura H, Miyake T, Hirai Y, Yamasaki O, Morizane S.
    J Dermatol Sci; 2019 Oct 01; 96(1):26-32. PubMed ID: 31501002
    [Abstract] [Full Text] [Related]

  • 6. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
    Wiegmann H, Valentin F, Tarinski T, Liebau E, Loser K, Traupe H, Oji V.
    Br J Dermatol; 2019 Nov 01; 181(5):999-1008. PubMed ID: 30801672
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U, Wu Z, Schröder JM.
    PLoS One; 2009 Nov 01; 4(2):e4372. PubMed ID: 19190773
    [Abstract] [Full Text] [Related]

  • 9. Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis.
    Chavarria-Smith J, Chiu CPC, Jackman JK, Yin J, Zhang J, Hackney JA, Lin WY, Tyagi T, Sun Y, Tao J, Dunlap D, Morton WD, Ghodge SV, Maun HR, Li H, Hernandez-Barry H, Loyet KM, Chen E, Liu J, Tam C, Yaspan BL, Cai H, Balazs M, Arron JR, Li J, Wittwer AJ, Pappu R, Austin CD, Lee WP, Lazarus RA, Sudhamsu J, Koerber JT, Yi T.
    Sci Transl Med; 2022 Dec 14; 14(675):eabp9159. PubMed ID: 36516271
    [Abstract] [Full Text] [Related]

  • 10. Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis.
    Nomura H, Suganuma M, Takeichi T, Kono M, Isokane Y, Sunagawa K, Kobashi M, Sugihara S, Kajita A, Miyake T, Hirai Y, Yamasaki O, Akiyama M, Morizane S.
    Int J Mol Sci; 2020 Jan 30; 21(3):. PubMed ID: 32019242
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.
    Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A.
    J Exp Med; 2009 May 11; 206(5):1135-47. PubMed ID: 19414552
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
    Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A, Wagberg F, Brattsand M, Hachem JP, Leonardsson G, Hovnanian A.
    Mol Biol Cell; 2007 Sep 11; 18(9):3607-19. PubMed ID: 17596512
    [Abstract] [Full Text] [Related]

  • 16. Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use.
    Cheong KA, Lee TR, Lee AY.
    J Dermatol Sci; 2017 Aug 11; 87(2):192-200. PubMed ID: 28433430
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.
    Igawa S, Kishibe M, Minami-Hori M, Honma M, Tsujimura H, Ishikawa J, Fujimura T, Murakami M, Ishida-Yamamoto A.
    J Invest Dermatol; 2017 Feb 11; 137(2):449-456. PubMed ID: 27769847
    [Abstract] [Full Text] [Related]

  • 20. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A, Deraison C, Bonnart C, Bitoun E, Robinson R, O'Brien TJ, Wakamatsu K, Ohtsubo S, Takahashi H, Hashimoto Y, Dopping-Hepenstal PJ, McGrath JA, Iizuka H, Richard G, Hovnanian A.
    J Invest Dermatol; 2005 Feb 11; 124(2):360-6. PubMed ID: 15675955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.